Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL)

Bröckelmann: Takeda: Research Funding. Casasnovas:Roche: Consultancy, Research Funding; Takeda: Consultancy; Gilead: Consultancy. Hutchings:Takeda: Research Funding. von Tresckow:Novartis: Consultancy, Other: Travel and accomodation, Research Funding; Amgen: Other: honoraria for preparation of scientific educational events ; Celgene: Other: honoraria for preparation of scientific educational events; Takeda: Consultancy. Borchmann:Millennium: Research Funding. Moskowitz:Takeda: Research Funding. Engert:Takeda: Consultancy, Research Funding.